Comment on: "Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modelling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection".
Suramus Bio, Drug Development, J.P. Nagar I Phase, Bangalore, 560078, Karnataka, India. srini.suramus@yahoo.com.
Nuggehally R
NR
Srinivas
D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D008297:Male; D011725:Pyridines / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D014230:Triazoles / Q000008:administration & dosage* / Q000493:pharmacokinetics*
D018501:Antirheumatic Agents; D011725:Pyridines; D014230:Triazoles